HUE042643T2 - Lactobacillus reuteri ATCC PTA 6475 csontveszteség - Google Patents

Lactobacillus reuteri ATCC PTA 6475 csontveszteség

Info

Publication number
HUE042643T2
HUE042643T2 HUE13800449A HUE13800449A HUE042643T2 HU E042643 T2 HUE042643 T2 HU E042643T2 HU E13800449 A HUE13800449 A HU E13800449A HU E13800449 A HUE13800449 A HU E13800449A HU E042643 T2 HUE042643 T2 HU E042643T2
Authority
HU
Hungary
Prior art keywords
mammals
prevention
treatment
bone loss
atcc pta
Prior art date
Application number
HUE13800449A
Other languages
English (en)
Inventor
Eamonn Connolly
Robert Allen Britton
Laura Rae Mccabe
Original Assignee
Biogaia Ab
Univ Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab, Univ Michigan State filed Critical Biogaia Ab
Publication of HUE042643T2 publication Critical patent/HUE042643T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HUE13800449A 2012-06-04 2013-06-04 Lactobacillus reuteri ATCC PTA 6475 csontveszteség HUE042643T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261689338P 2012-06-04 2012-06-04

Publications (1)

Publication Number Publication Date
HUE042643T2 true HUE042643T2 (hu) 2019-07-29

Family

ID=49712339

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13800449A HUE042643T2 (hu) 2012-06-04 2013-06-04 Lactobacillus reuteri ATCC PTA 6475 csontveszteség

Country Status (17)

Country Link
US (4) US20150150917A1 (hu)
EP (2) EP3456334B1 (hu)
JP (1) JP6193981B2 (hu)
KR (2) KR20150028968A (hu)
CN (1) CN104755091B (hu)
AU (2) AU2013272330B2 (hu)
CA (1) CA2875841C (hu)
DK (2) DK3456334T3 (hu)
ES (2) ES2711427T3 (hu)
HK (1) HK1211847A1 (hu)
HR (1) HRP20190162T1 (hu)
HU (1) HUE042643T2 (hu)
LT (1) LT2854826T (hu)
PL (2) PL2854826T3 (hu)
SI (1) SI2854826T1 (hu)
TR (1) TR201901771T4 (hu)
WO (1) WO2013184064A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101915904B1 (ko) 2016-08-12 2018-11-06 한국식품연구원 락토바실러스 인테스티날리스를 포함하는 갱년기 예방 또는 치료용 조성물
KR102120479B1 (ko) * 2018-10-30 2020-06-09 주식회사 종근당바이오 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
CA3127806A1 (en) * 2019-02-05 2020-08-13 Elanco Us Inc. Probiotic compositions comprising lactobacillus reuteri strains and methods of use
KR102080498B1 (ko) * 2019-08-23 2020-02-24 정영옥 페룰산 및 유산균을 유효성분으로 포함하는 골감소증 개선 또는 예방용 식품 조성물
WO2021112041A1 (ja) * 2019-12-02 2021-06-10 雪印メグミルク株式会社 骨強化剤
CN111718903A (zh) * 2020-06-24 2020-09-29 江南大学 一种筛选可预防和/或治疗骨质疏松的药物的方法
CN114711429B (zh) * 2021-06-08 2023-11-17 青岛蔚蓝生物股份有限公司 一株具有增强骨健康作用的罗伊氏乳杆菌及其应用
CN114634901B (zh) * 2022-05-18 2022-08-30 微康益生菌(苏州)股份有限公司 一种促进骨骼健康的干酪乳杆菌lc16及其培养方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005537236A (ja) * 2002-06-13 2005-12-08 ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド,コーク プロバイオティック治療
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
JP5144263B2 (ja) * 2005-07-26 2013-02-13 ネステク ソシエテ アノニム 抗肥満剤および抗肥満食品
WO2008028300A1 (en) * 2006-09-07 2008-03-13 Mcgill University Oral polymeric membrane feruloyl esterase producing bacteria formulation
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis

Also Published As

Publication number Publication date
US20180200313A1 (en) 2018-07-19
AU2018200524A1 (en) 2018-02-15
EP2854826A4 (en) 2016-07-06
AU2013272330A1 (en) 2015-01-15
CN104755091A (zh) 2015-07-01
US20190142879A1 (en) 2019-05-16
ES2711427T3 (es) 2019-05-03
DK2854826T3 (en) 2019-03-11
ES2711427T8 (es) 2019-06-20
CA2875841A1 (en) 2013-12-12
KR102191537B1 (ko) 2020-12-16
EP3456334B1 (en) 2020-11-11
SI2854826T1 (sl) 2019-03-29
HK1211847A1 (en) 2016-06-03
EP3456334A1 (en) 2019-03-20
EP2854826A1 (en) 2015-04-08
HRP20190162T1 (hr) 2019-04-05
AU2013272330B2 (en) 2017-11-02
EP2854826B1 (en) 2018-11-14
US10537598B2 (en) 2020-01-21
JP6193981B2 (ja) 2017-09-06
PL3456334T3 (pl) 2021-05-04
PL2854826T3 (pl) 2019-06-28
CN104755091B (zh) 2020-07-21
KR20200044134A (ko) 2020-04-28
LT2854826T (lt) 2019-02-11
TR201901771T4 (tr) 2019-03-21
US9968643B2 (en) 2018-05-15
US20150150917A1 (en) 2015-06-04
DK3456334T3 (da) 2021-01-25
JP2015526389A (ja) 2015-09-10
US10232001B2 (en) 2019-03-19
WO2013184064A1 (en) 2013-12-12
EP2854826B9 (en) 2019-05-08
CA2875841C (en) 2021-02-02
ES2847424T3 (es) 2021-08-03
KR20150028968A (ko) 2015-03-17
US20170128501A1 (en) 2017-05-11
AU2018200524B2 (en) 2019-07-18

Similar Documents

Publication Publication Date Title
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
SI2854826T1 (sl) Lactobacillus reuteri ATCC PTA6475 za uporabo v preprečevanju ali zdravljenju kostne izgube pri sesalcih
HK1220129A1 (zh) 益生菌菌株用於治療或預防骨質疏鬆
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
HK1223274A1 (zh) 用於治療淺表病變的組合物
EP2651439A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HUMAN ADENOVIRUS 36 INFECTION
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
SI2854910T1 (sl) Nivoji ceramida pri zdravljenju in preprečevanju okužb
PL2457576T3 (pl) Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
EP2753363A4 (en) MG53 COMPOSITIONS AND METHOD FOR THE TREATMENT AND PREVENTION OF RESPIRATORY INFLUENZES
HK1211221A1 (en) Formulations for the treatment and prevention of obesity
EP2814491A4 (en) FORMULATIONS AND METHODS FOR TREATING OR PROPHYLAXIS OF PRE-MCI AND / OR PRE-ALZHEIMER ILLNESSES
SI3442547T1 (sl) Lactobacillus reuteri MM4-1A za uporabo pri zdravljenju ali preprečevanju motenj avtističnega spektra
PL2731584T3 (pl) Zastosowanie związków oligosacharydowych do zapobiegania i leczenia patologicznych blizn
IL222482A0 (en) Methods and compositions for the treatment of fluid accumulation in and/or under the retina
GB2524474B (en) Composition and use of lactobacillus reuteri GMNL-89 in treating type 2 diabetes
HK1206598A1 (en) Eprotirome for use in the prevention and or treatment of hair disorders and compositions thereof
IL243237A0 (en) Methods and preparations for the treatment of fluid accumulation in and/or under the retina
AU2012900286A0 (en) "Methods of treatment or prophylaxis"
PT2389936E (pt) Aminaftona para utilização no tratamento e/ou prevenção de enxaqueca